Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

AI for diabetic retinopathy

Industry Watcher’s Digest

Buzzworthy developments of the past few days.

Thumbnail

Radiology groups slam UnitedHealthcare decision they say was inspired by ‘science-harvesting mercenaries’

UHC has labeled an IR service docs have been delivering for 9 years as “unproven and not medically necessary due to insufficient evidence of efficacy." 

Medicare money payment physician

UnitedHealth’s Optum to acquire 9-state multispecialty radiology provider

Dallas-based Steward Medical Group spans 450 practices, employing over 1,700 providers including 180-plus radiologists. 
 

equity

Radiologists and other docs voice support for DEI in medicine while lawmakers aim to kill it

The AMA and others issued a statement, labeling diversity, equity and inclusion as a “means to help improve the health of our nation.” 

physician artificial intelligence

5 tips on AI adoption from a frontline physician champion

AI adoption for real-world healthcare settings can’t happen in a vacuum. 

Medicare money payment reimbursement dollar decline george washington

Imaging’s total share of US healthcare spending plummets as others record gains

The percentage of patients who received imaging services also declined from 46% in 2010 down to 40% by 2021, experts wrote in Health Affairs Scholar

Thumbnail

Phoenix Radiology inks deal with critical access hospital after previous imaging partner departs

Clarkston, Washington-based TriState Health had worked with Twin Cities Radiology for 25 years, with the practice ending the relationship due to retirement. 

FDA approves new drugs for pulmonary arterial hypertension from Johnson & Johnson, Merck

Cardiologists now have two more tools to help them combat PAH, a rare vascular condition that often leads to heart failure.